Video

It Takes a Team to Build Personalized Care for Type 2 Diabetes

Diana McNeill, MD, of Duke University Medical Center moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. The topic of discussion? Personalized care in type 2 diabetes.

It goes without saying that not every patient with the same health condition is similar. In the case of type 2 diabetes, teamwork can better help patients manage their disease with personalized care.

Diana McNeill, MD, professor of medicine and assistant professor of obstetrics and gynecology at Duke University Medical Center in Durham, North Carolina moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. With panelists Steven Edelman, MD, and M. Sue Kirkman, MD, the physicians talked about preventing clinical inertia in the management of type 2 diabetes and the importance of personalized care.

McNeill spoke with MD Magazine about the discussion and said that the type 2 diabetes epidemic puts many patients in front of primary care physicians before an endocrinologist.

“When a patient comes into your office, do you examine them and check their feet and make sure that they’ve had all their diabetes healthcare maintenance completed?” McNeill said. “And once you do do that, what target of diabetes control are you aiming for? And is it appropriate for their age and comorbidities?”

She went on to explain that the American Diabetes Association has changed their thinking on the goals of type 2 diabetes care. How? Watch the video above and gain insight on personalized care.

>>> More Coverage from ACP 2017

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.